8 results on '"Andrea Ulrichsen"'
Search Results
2. Affective lability as a prospective predictor of subsequent bipolar disorder diagnosis: a systematic review
- Author
-
Rosie H. Taylor, Andrea Ulrichsen, Allan H. Young, and Rebecca Strawbridge
- Subjects
Bipolar disorder ,Systematic review ,Affective lability ,Mood instability ,Prospective ,Predictor ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 ,Neurophysiology and neuropsychology ,QP351-495 - Abstract
Abstract Objectives The early pathogenesis and precursors of Bipolar Disorder (BD) are poorly understood. There is some cross-sectional and retrospective evidence of affective lability as a predictor of BD, but this is subject to recall biases. The present review synthesises the prospective evidence examining affective lability and the subsequent development of BD at follow-up. Methods The authors performed a systematic search of PubMed, PsycInfo and Embase (1960–June 2020) and conducted hand searches to identify studies assessing affective lability (according to a conceptually-inclusive definition) at baseline assessment in individuals without a BD diagnosis, and a longitudinal follow-up assessment of bipolar (spectrum) disorders. Results are reported according to the PRISMA guidelines, and the synthesis without meta-analysis (SWiM) reporting guidelines were used to strengthen the narrative synthesis. The Newcastle–Ottawa Scale was used to assess risk of bias (ROB). Results 11 articles describing 10 studies were included. Being identified as having affective lability at baseline was associated with an increased rate of bipolar diagnoses at follow-up; this association was statistically significant in six of eight studies assessing BD type I/II at follow-up and in all four studies assessing for bipolar spectrum disorder (BSD) criteria. Most studies received a ‘fair’ or ‘poor’ ROB grade. Conclusions Despite a paucity of studies, an overall association between prospectively-identified affective lability and a later diagnosis of BD or BSD is apparent with relative consistency between studies. This association and further longitudinal studies could inform future clinical screening of those who may be at risk of BD, with the potential to improve diagnostic accuracy and facilitate early intervention.
- Published
- 2021
- Full Text
- View/download PDF
3. Economic impact of reducing treatment gaps in depression
- Author
-
Paul McCrone, Allan H. Young, Roland Zahn, Jonas Eberhard, Danuta Wasserman, Paolo Brambilla, Judit Balazs, Jose Caldas-de-Almeida, Andrea Ulrichsen, Vladmir Carli, Ana Antunes, Giandomenico Schiena, Vinciane Quoidbach, Patrice Boyer, and Rebecca Strawbridge
- Subjects
cost ,depression ,economics ,treatment ,gaps ,Psychiatry ,RC435-571 - Abstract
Abstract Background Major depressive disorder (MDD) is highly prevalent across Europe. While evidence-based treatments exist, many people with MDD have their condition undetected and/or untreated. This study aimed to assess the cost-effectiveness of reducing treatment gaps using a modeling approach. Methods A decision-tree model covering a 27-month time horizon was used. This followed a care pathway where MDD could be detected or not, and where different forms of treatment could be provided. Expected costs pertaining to Germany, Hungary, Italy, Portugal, Sweden, and the UK were calculated and quality-adjusted life years (QALYs) were estimated. The incremental costs per QALY of reducing detection and treatment gaps were estimated. Results The expected costs with a detection gap of 69% and treatment gap of 50% were €1236 in Germany, €476 in Hungary, €1413 in Italy, €938 in Portugal, €2093 in Sweden, and €1496 in the UK. The incremental costs per QALY of reducing the detection gap to 50% ranged from €2429 in Hungary to €10,686 in Sweden. The figures for reducing the treatment gap to 25% ranged from €3146 in Hungary to €13,843 in Sweden. Conclusions Reducing detection and treatment gaps, and maintaining current patterns of care, is likely to increase healthcare costs in the short term. However, outcomes are improved, and reducing these gaps to 50 and 25%, respectively, appears to be a cost-effective use of resources.
- Published
- 2023
- Full Text
- View/download PDF
4. Care pathways for people with major depressive disorder: A European Brain Council Value of Treatment study
- Author
-
Rebecca Strawbridge, Paul McCrone, Andrea Ulrichsen, Roland Zahn, Jonas Eberhard, Danuta Wasserman, Paolo Brambilla, Giandomenico Schiena, Ulrich Hegerl, Judit Balazs, Jose Caldas de Almeida, Ana Antunes, Spyridon Baltzis, Vladmir Carli, Vinciane Quoidbach, Patrice Boyer, and Allan H. Young
- Subjects
Care pathways ,diagnosis ,major depressive disorder ,treatment ,Psychiatry ,RC435-571 - Abstract
Abstract Background Despite well-established guidelines for managing major depressive disorder, its extensive disability burden persists. This Value of Treatment mission from the European Brain Council aimed to elucidate the nature and extent of “gaps” between best-practice and current-practice care, specifically to: 1. Identify current treatment gaps along the care pathway and determine the extent of these gaps in comparison with the stepped-care model and 2. Recommend policies intending to better meet patient needs (i.e., minimize treatment gaps). Methods After agreement upon a set of relevant treatment gaps, data pertaining to each gap were gathered and synthesized from several sources across six European countries. Subsequently, a modified Delphi approach was undertaken to attain consensus among an expert panel on proposed recommendations for minimizing treatment gaps. Results Four recommendations were made to increase the depression diagnosis rate (from ~50% episodes), aiming to both increase the number of patients seeking help, and the likelihood of a practitioner to correctly detect depression. These should reduce time to treatment (from ~1 to ~8 years after illness onset) and increase rates of treatment; nine further recommendations aimed to increase rates of treatment (from ~25 to ~50% of patients currently treated), mainly focused on targeting the best treatment to each patient. To improve follow-up after treatment initiation (from ~30 to ~65% followed up within 3 months), seven recommendations focused on increasing continuity of care. For those not responding, 10 recommendations focused on ensuring access to more specialist care (currently at rates of ~5–25% of patients). Conclusions The treatment gaps in depression care are substantial and concerning, from the proportion of people not entering care pathways to those stagnating in primary care with impairing and persistent illness. A wide range of recommendations can be made to enhance care throughout the pathway.
- Published
- 2022
- Full Text
- View/download PDF
5. Comparing measurements of lithium treatment efficacy in people with bipolar disorder: systematic review and meta-analysis
- Author
-
Andrea Ulrichsen, Elliot Hampsey, Rosie H. Taylor, Romayne Gadelrab, Rebecca Strawbridge, and Allan H. Young
- Subjects
Psychiatry and Mental health - Abstract
Background Lithium has long been recognised as an effective treatment for bipolar disorder. Its relative efficacy has been measured with a diverse range of clinical outcomes, resulting in differences in efficacy reporting that have not been systematically reviewed. Aims We aimed to identify and compare the various measures of lithium efficacy employed in interventional studies for people with bipolar disorder. Method Database (PubMed, Web of Science) and hand searches were performed to identify studies that assessed a clinical response in patients with bipolar disorder who received lithium, up to the end of 2021. We included primary human interventional studies without excluding specific study designs, bipolar disorder subtypes, duration or dosage of lithium treatment. Continuous outcome effects were meta-analysed; binary outcomes were synthesised visually and narratively. The Cochrane risk-of-bias tool was used to assess study-level risk of bias. Results Seventy-one studies were included (N = 30 542). Approximately two-thirds of participants attained a clinically significant improvement in manic or depressive symptoms, and over 50% achieved remission. About a third required hospital admission (study length 2–12 years) and around 50% needed further treatment to stay well or had recurrence of symptoms; the latter two outcomes tended to be assessed over long-term maintenance periods. Conclusions An abundance of measurements have been used to assess lithium's clinical effects, across several study designs. Despite the resultant high heterogeneity, an overall picture of lithium's effects emerges that supports previous literature; between half and two-thirds of patients respond well to lithium across varying outcome measures, baseline mood states, study durations and bipolar disorder subtypes.
- Published
- 2023
- Full Text
- View/download PDF
6. A large-scale environmental strontium isotope baseline map of Portugal for archaeological and paleoecological provenance studies
- Author
-
Hannah F. James, Shaun Adams, Malte Willmes, Kate Mathison, Andrea Ulrichsen, Rachel Wood, Antonio C. Valera, Catherine J. Frieman, Rainer Grün, Analytical, Environmental & Geo-Chemistry, and Multidisciplinary Archaeological Research Institute
- Subjects
Mobility ,Archeology ,Soil ,Kriging ,Archaeology ,archaeology ,Isoscape ,Plant ,mobility ,soil - Abstract
Strontium isotopes (Sr-87/Sr-86) provide valuable information to help reconstruct past mobility. For the analysis of archaeological tooth enamel to provide a direct assessment of mobility, a comparison to the baseline Sr-87/Sr-86 in a region is required. In this study, a large-scale Sr-87/Sr-86 baseline of Portugal is created based on 151 paired plant and soil leachate samples combined with previously published data (20 additional plant and 33 additional soil leachate sites). Spatial patterns of Sr-87/Sr-86 are evident, following Portugal's geology and terrain, with higher Sr-87/Sr-86 in the granite dominated north and further inland. Influences from sea spray are observed along the coastal regions of the country. The bioavailable strontium range for Portugal is 0.70575-0.73487, and paired plant-soil leachate site measurements show a strong positive relationship. Empirical Bayesian Kriging (EBK) alongside mean Sr-87/Sr-86 per geological unit are used to provide predictive surfaces for bioavailable Sr-87/Sr-86. We find that the addition of archaeological site-specific measurements is required in archaeological mobility studies to ensure local-scale Sr-87/Sr-86 variation is captured, illustrated in this study using the Late Middle Neolithic to Early Bronze Age site of Perdigoes. The bioavailable strontium isoscape for Portugal provides a baseline map for future archaeological and palaeoecological studies in this region and contributes to the global efforts to map strontium isotope variability. ARC Discovery Project DP160100811 Grant agreement number 948913 info:eu-repo/semantics/publishedVersion
- Published
- 2022
7. Affective lability as a prospective predictor of subsequent bipolar disorder diagnosis: a systematic review
- Author
-
Rebecca Strawbridge, Andrea Ulrichsen, Allan H. Young, and Rosie H Taylor
- Subjects
Neurophysiology and neuropsychology ,medicine.medical_specialty ,Affective lability ,Neurology ,Bipolar disorder ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Review ,PsycINFO ,Medicine ,Spectrum disorder ,Medical diagnosis ,Risk factor ,Mood instability ,Biological Psychiatry ,Recall ,Bipolar spectrum ,business.industry ,QP351-495 ,medicine.disease ,Prospective ,Psychiatry and Mental health ,Systematic review ,Risk-factor ,Psychopharmacology ,business ,Predictor ,RC321-571 ,Clinical psychology - Abstract
Objectives The early pathogenesis and precursors of Bipolar Disorder (BD) are poorly understood. There is some cross-sectional and retrospective evidence of affective lability as a predictor of BD, but this is subject to recall biases. The present review synthesises the prospective evidence examining affective lability and the subsequent development of BD at follow-up. Methods The authors performed a systematic search of PubMed, PsycInfo and Embase (1960–June 2020) and conducted hand searches to identify studies assessing affective lability (according to a conceptually-inclusive definition) at baseline assessment in individuals without a BD diagnosis, and a longitudinal follow-up assessment of bipolar (spectrum) disorders. Results are reported according to the PRISMA guidelines, and the synthesis without meta-analysis (SWiM) reporting guidelines were used to strengthen the narrative synthesis. The Newcastle–Ottawa Scale was used to assess risk of bias (ROB). Results 11 articles describing 10 studies were included. Being identified as having affective lability at baseline was associated with an increased rate of bipolar diagnoses at follow-up; this association was statistically significant in six of eight studies assessing BD type I/II at follow-up and in all four studies assessing for bipolar spectrum disorder (BSD) criteria. Most studies received a ‘fair’ or ‘poor’ ROB grade. Conclusions Despite a paucity of studies, an overall association between prospectively-identified affective lability and a later diagnosis of BD or BSD is apparent with relative consistency between studies. This association and further longitudinal studies could inform future clinical screening of those who may be at risk of BD, with the potential to improve diagnostic accuracy and facilitate early intervention.
- Published
- 2021
- Full Text
- View/download PDF
8. Strontium in Portugal: merging datasets to create a robust strontium baseline
- Author
-
Hannah James, Christina Cheung, Jacob Griffith, Christophe Snoeck, Filipa Cortesão Silva, Rita Peyroteo Stjerna, Ana Cristina Araújo, Ana Maria Costa, Rainer Grün, Frieman, Catherine J., Valera, Antonio C., Rachel Wood, Andrea Ulrichsen, Kate Mathison, Malte Willmes, Shaun Adams, Chemistry, Analytical, Environmental & Geo-Chemistry, Multidisciplinary Archaeological Research Institute, History, Archeology, Arts, Philosophy and Ethics, and Faculty of Sciences and Bioengineering Sciences
- Abstract
The creation of bioavailable strontium baseline maps are critical for interpreting bioarchaeological data. With the increasing production of local archaeological site-specific, regional or national maps, devising an approach for combining these datasets to create larger or higher density isoscapes is crucial. Using Portugal as a case study, this presentation will discuss how combining different archives and scales of strontium isotope data can provide a robust baseline for archaeological mobility studies. The presentation will introduce the first country-wide bioavailable strontium baseline for Portugal, created using paired plant and soil leachate measurements from 151 sampling sites. Our dataset will be used as a foundation, with additional data from published archaeological site baselines (using modern plant, human bones and faunal remains), our recently collected regional plant samples, and published European and global datasets (on agricultural soils and mineral waters) compared. Plant samples provide the majority of strontium data in Portugal, and are a solid base for archaeological studies. This approach provides an opportunity to compare different archives to this plant base to highlight the variability in the archives used for strontium mapping and to highlight inadequacies in our current sampling strategies. Comparing datasets also allows for an evaluation of isotopic variation on varying scales; wide-scale sampling highlights how the diverse geological, geographical, and climatic regions of Portugal lead to an interesting spatial distribution of 87Sr/86Sr across the country. Furthermore, regional and site-specific sampling allows for the assessment of residential mobility and the range of landscapes used by past human populations. Reconstructing palaeomobility patterns requires a full picture of isotopic diversity at both the local, regional and broader level, combining datasets of varying scales moves us one step closer to creating the robust baselines required.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.